Phreesia SG&A Expenses 2019-2025 | PHR
Phreesia Annual SG&A Expenses (Millions of US $) |
|
---|---|
2025 | $198 |
2024 | $227 |
2023 | $232 |
2022 | $175 |
2021 | $83 |
2020 | $63 |
2019 | $46 |
2018 | $44 |
Phreesia Quarterly SG&A Expenses (Millions of US $) |
|
---|---|
2025-01-31 | $47 |
2024-10-31 | $50 |
2024-07-31 | $50 |
2024-04-30 | $51 |
2024-01-31 | $55 |
2023-10-31 | $57 |
2023-07-31 | $58 |
2023-04-30 | $57 |
2023-01-31 | $56 |
2022-10-31 | $56 |
2022-07-31 | $58 |
2022-04-30 | $61 |
2022-01-31 | $59 |
2021-10-31 | $50 |
2021-07-31 | $38 |
2021-04-30 | $28 |
2021-01-31 | $25 |
2020-10-31 | $21 |
2020-07-31 | $20 |
2020-04-30 | $18 |
2020-01-31 | $18 |
2019-10-31 | $16 |
2019-07-31 | $16 |
2019-04-30 | $14 |
2019-01-31 | |
2018-10-31 | $12 |
2018-07-31 | $11 |
2018-01-31 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Information Systems | $1.510B | $0.420B |
Phreesia Inc. provides a patient intake management platform. The company's SaaS platform engages patients in their care and provides a modern, consistent experience, while enabling healthcare organizations to optimize their staffing, boost profitability and enhance clinical care. Phreesia Inc. is based in New York. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Veeva Systems (VEEV) | United States | $39.499B | 54.56 |
Hims & Hers Health (HIMS) | United States | $14.471B | 150.35 |
Tempus AI (TEM) | United States | $11.278B | 0.00 |
Inspire Medical Systems (INSP) | United States | $4.503B | 70.35 |
IRhythm Technologies (IRTC) | United States | $4.501B | 0.00 |
Privia Health (PRVA) | United States | $3.050B | 208.50 |
Enovis (ENOV) | United States | $2.060B | 11.48 |
Clover Health Investments (CLOV) | United States | $1.807B | 0.00 |
Schrodinger (SDGR) | United States | $1.722B | 0.00 |
Omnicell (OMCL) | United States | $1.310B | 23.11 |
Azenta (AZTA) | United States | $1.258B | 58.45 |
10x Genomics (TXG) | United States | $1.148B | 0.00 |
Fulgent Genetics (FLGT) | United States | $0.620B | 0.00 |
Butterfly Network (BFLY) | United States | $0.581B | 0.00 |
Talkspace (TALK) | United States | $0.499B | 149.00 |
Veradigm (MDRX) | United States | $0.455B | 0.00 |
Claritev (CTEV) | United States | $0.450B | 0.00 |
Standard BioTools (LAB) | United States | $0.410B | 0.00 |
TruBridge (TBRG) | United States | $0.376B | 834.67 |
Health Catalyst (HCAT) | United States | $0.283B | 0.00 |
Nyxoah SA (NYXH) | Belgium | $0.214B | 0.00 |
SOPHiA GENETICS SA (SOPH) | Switzerland | $0.197B | 0.00 |
EUDA Health Holdings (EUDA) | Singapore | $0.142B | 0.00 |
Pulmonx (LUNG) | United States | $0.138B | 0.00 |
American Well (AMWL) | United States | $0.116B | 0.00 |
MDxHealth SA (MDXH) | Belgium | $0.099B | 0.00 |
CareCloud (CCLD) | United States | $0.089B | 3.39 |
Outset Medical (OM) | United States | $0.070B | 0.00 |
111 (YI) | China | $0.067B | 0.00 |
Retrieve Medical Holdings (RMHI) | United States | $0.059B | 0.00 |
P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
HeartBeam (BEAT) | United States | $0.052B | 0.00 |
Zepp Health (ZEPP) | Netherlands | $0.042B | 0.00 |
Zhongchao (ZCMD) | China | $0.032B | 0.00 |
ImmunoPrecise Antibodies (IPA) | Canada | $0.023B | 0.00 |
Bullfrog AI Holdings (BFRG) | United States | $0.016B | 0.00 |
MSP Recovery (MSPR) | United States | $0.013B | 0.00 |
Precipio (PRPO) | United States | $0.012B | 0.00 |
Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
Streamline Health Solutions (STRM) | United States | $0.010B | 0.00 |
Movano (MOVE) | United States | $0.007B | 0.00 |
Mobile-health Network Solutions (MNDR) | Singapore | $0.004B | 0.00 |
Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
HeartSciences (HSCS) | United States | $0.004B | 0.00 |
Healthcare Triangle (HCTI) | United States | $0.000B | 0.00 |
Future Health ESG (FHLT) | United States | $0.000B | 0.00 |